Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Fee Klupp - , Universität Heidelberg (Autor:in)
  • Johannes Diers - , Universität Heidelberg (Autor:in)
  • Christoph Kahlert - , Medizinische Klinik und Poliklinik III, Bereich Allgemeinmedizin, Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universität Heidelberg (Autor:in)
  • Lena Neumann - , Universität Heidelberg (Autor:in)
  • Niels Halama - , Universität Heidelberg (Autor:in)
  • Clemens Franz - , Universität Heidelberg (Autor:in)
  • Thomas Schmidt - , Universität Heidelberg (Autor:in)
  • Felix Lasitschka - , Universität Heidelberg, Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Arne Warth - , Universität Heidelberg (Autor:in)
  • Juergen Weitz - , Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Technische Universität Dresden (Autor:in)
  • Moritz Koch - , Technische Universität Dresden, Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie (Autor:in)
  • Martin Schneider - , Universität Heidelberg (Autor:in)
  • Alexis Ulrich - , Universität Heidelberg (Autor:in)

Abstract

Background: Signal transducer and activator of transcription proteins (STATs) are crucial regulators of cell growth and differentiation; however, their specific prognostic impact in human colon cancer has only been studied to limited extent. We aimed to assess the prognostic significance of specific STAT expression patterns in colon carcinoma. Methods: Protein expression patterns of activated STAT1, STAT3, STAT4, and STAT5 in human colon carcinoma tissue and corresponding healthy mucosa (n = 104) were assessed using multiplex bead-based immunoassay technologies. Expression patterns were correlated with clinical and survival data. Immunohistochemistry was performed to assess spatial expression of STAT3 and STAT5. Results: STAT3 was underexpressed whereas STAT4 and STAT5 were overexpressed in colon carcinoma tissue. Primary tumors from patients with distant metastases (M1) displayed significantly increased expression of STAT1 and STAT3 but decreased expression of STAT4 and STAT5. Increased tumor expression of STAT1 or STAT3 was associated with impaired patient survival, whereas increased expression of STAT4 or STAT5 correlated with improved survival. Multivariate analysis identified an increased STAT3/STAT5 expressional ratio as an adverse prognostic marker in colon cancer patients. Conclusions: The tumor progression-associated transcription factors STAT3, STAT4, and STAT5 are differently expressed in colon carcinoma tissue and colon mucosa. Moreover, the STAT3/STAT5 expression ratio is an independent prognostic marker in colon cancer patients.

Details

OriginalspracheEnglisch
Seiten (von - bis)1548-1555
Seitenumfang8
FachzeitschriftAnnals of surgical oncology
Jahrgang22
PublikationsstatusVeröffentlicht - 1 Dez. 2015
Peer-Review-StatusJa

Externe IDs

PubMed 25773877

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete